Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

Cardio3 completes private placement

Country: Belgium

Belgium-based Cardio3 BioSciences SA has raised €32 million through a private placement of its shares with investors in the US and Europe. The funds will support its cell therapy for the treatment of heart failure as well as recently acquired chimeric antigen receptor (CAR) technology.

Read more

Re-setting the compass at UCB

Country: Belgium

Two months into his new job as chief executive of UCB SA, Jean-Christophe Tellier said the plan is to keep the company’s strategy focused on central nervous system disorders and immunology, whilst taking some risks on experimental treatments for Parkinson’s disease and lupus erythematosus.

Read more

Ablynx reports 37% revenue gain

Country: Belgium

Read more

FDA approves Toujeo for diabetes

Country: France

Read more

Prexton raises Series A money for CNS

Country: Switzerland

Read more

Shire buys another rare-disease firm

Country: United States

Read more

BMS acquires new oncology assets

Country: United States

Read more

FDA approves Farydak for multiple myeloma

Country: United States

Read more

Merck partners in metabolic disease arena

Country: United States

Read more

Innate progresses its natural killer platform

Country: France

Read more

Heptares to be acquired by Sosei Group

Country: United Kingdom

Read more

Sobi anticipates 2015 sales increase

Country: Sweden

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Ebola epidemic moves fast but response is gaining

EbolaFeb2015.pdf

Highlights of the February 2015 MedNous issue

The February 2015 MedNous features:

Latest Mednous cover
  • Public Health
    Getting Ebola under control
  • Research Strategy
    What does the brain hear?
    Interview with Autifony
  • Business Strategy
    A turning point for biopharma?
    By Jean-Claude Muller
  • Commentary
    Tackling infections associated with cystic fibrosis
    by Deborah O’Neil
  • Commentary
    Innovation points to a bright future
    by Mick Cooper
  • Big Pharma Review
    Deriving value from asset swaps
    By Martin Gouldstone

The latest MedNous journal. Subscribe to download.

Recent Appointments